Viewing posts for the category Elixinol (ASX:EXL)

Elixinol Global (ASX:EXL) HY 2019 Stock Analysis

Elixinol Global (ASX:EXL): It's Not Easy Being Green

It’s high time we checked in on Elixinol Global (ASX:EXL) post the release of the company’s 1H19 results late last month and following a very busy last several months which we’ll summarise in this update. This time however we’re going to do things backwards and start with the financials – where some of the developments since we last published on Elixinol in February have begun to manifest. Then we’ll triangulate the numbers to the narrative to understand where the company is at this point in time. 

read more

Elixinol (ASX:EXL) Quarterly Cashflow Q1 2019: A Weak Result

Elixinol Global Ltd (ASX:EXL) Quarterly Cashflow Q1 2019

Cannabis oil company Elixinol (ASX:EXL) yesterday released its quarterly cashflow report, showing that cash receipts were not impressive, given that it operates in a growing market. As you can see below, the receipts from customers decreased significantly, but expenses did not -- leading to a very poor operating result.

read more

Elixinol (ASX:EXL) FY 2018 Full Year Results: Greens Are Good For You

Elixinol (ASX:EXL) FY 2018 Full Year Results: Greens Are Good For You

Elixinol Global (ASX: EXL) released its full year FY18 results today and followed up with an illuminating investor call. The share price climbed ~7% to $3.55 in response (not far from the all-time high of $3.69 reached earlier this month) – though there arguably wasn’t a whole heap of new or surprising information in today’s news.

read more

Elixinol (ASX:EXL) Q4 2018 Quarterly Update

Elixinol Global Ltd (ASX:EXL): Growing But Still Early Stage

read more